首页> 外文OA文献 >5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial

【2h】

5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial

机译：随机对照试验的5年随机对照试验的随访者随机血液毒性酸患者在乳腺癌后预防乳腺癌患者乳腺癌后的乳腺癌患者（Charifen）在Letrozole中开始：N03CC（联盟）试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nina D. Wagner-Johnston; Jeff A. Sloan; Heshan Liu; Ann E. Kearns; Stephanie L. Hines; Suneetha Puttabasavaiah; Shaker R. Dakhil; Jacqueline M. Lafky; Edith A. Perez; Charles L. Loprinzi;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial [J] . Wagner-Johnston, N.D., Sloan, Cancer: A Journal of the American Cancer Society . 2015,第15期

机译：他莫昔芬治疗后开始来曲唑的乳腺癌绝经后妇女预防立即骨质酸与延迟唑来膦酸随机对照试验的5年随访：N03CC（Alliance）试验
2. Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC. [J] . Hines SL, Mincey B, Dentchev T Breast cancer research and treatment. . 2009,第3期

机译：立即和延迟唑来膦酸预防乳腺癌的绝经后妇女的骨丢失，他莫昔芬-N03CC后开始来曲唑治疗。
3. The protective effect of zoledronic acid on bone loss in postmenopausal women with early breast cancer treated with sequential tamoxifen and letrozole: a prospective, randomized, phase II trial. [J] . Tamar Safra, Rinat Bernstein-Molho, Julia Greenberg, Oncology: International Journal of Cancer Research and Treatment . 2011,第5a6期

机译：唑来膦酸对连续性他莫昔芬和来曲唑治疗的绝经后早期乳腺癌妇女骨丢失的保护作用：一项前瞻性，随机，II期试验。
4. META-ANALYSIS OF RANDOMIZED TRIALS OF TAMOXIFEN FOR EARLY BREAST CANCER [C] . V. ALBA-FERNANDEZ, J. MUNOZ-GARCIA Applied Simulation and Modelling . 2001

机译：他莫昔芬用于早期乳腺癌的随机试验的meta分析
5. Is there an app for that? An exploratory randomized controlled trial of app-based mindfulness training for women with breast cancer. [D] . Rosen, Kristen D. 2016

机译：有针对这样的应用吗？基于应用程序的正念训练对乳腺癌女性的探索性随机对照试验。
6. 5-year Follow-up of a Randomized Controlled Trial of Immediate versus Delayed Zoledronic Acid for Prevention of Bone Loss in Postmenopausal Women with Breast Cancer Starting Letrozole after Tamoxifen: N03CC (Alliance) [O] . Nina D. Wagner-Johnston, Jeff A. Sloan, Heshan Liu, -1

机译：5年随访的即刻和延迟唑来膦酸随机对照试验用于预防在他莫昔芬后开始来曲唑治疗的绝经后乳腺癌患者的骨丢失：N03CC（联盟）
7. Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): A double-blind, randomised controlled trial [O] . Forbes, John F., Sestak, Ivana, Holcombe, Chris, 2016

机译：阿那曲唑与他莫昔芬预防局部绝经后原位导管癌的绝经后妇女局部和对侧乳腺癌的预防（IBIS-II DCIS）：一项双盲，随机对照试验

5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial

著录项

引文网络

相似文献

相关主题

期刊订阅